Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial

Authors
Category Primary study
Year 2003
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Long-term monitoring for suitably selected patients with unexplained syncope will lead to more diagnoses than conventional testing. The cost per diagnosis will be lower and it is, therefore, the dominant strategy.
Epistemonikos ID: 0176a31f4661b348765ada1129a24b04677fd783
First added on: Apr 19, 2023